Application of four-dimensional cone beam computed tomography in lung cancer radiotherapy.


Journal

Radiation oncology (London, England)
ISSN: 1748-717X
Titre abrégé: Radiat Oncol
Pays: England
ID NLM: 101265111

Informations de publication

Date de publication:
17 Apr 2023
Historique:
received: 29 10 2022
accepted: 05 04 2023
medline: 19 4 2023
entrez: 18 4 2023
pubmed: 19 4 2023
Statut: epublish

Résumé

This study explored the application of four-dimensional cone beam computed tomography (4D CBCT) in lung cancer patients, seeking to improve the accuracy of radiotherapy and to establish a uniform protocol for the application of 4D CBCT in radiotherapy for lung cancer. 4D CBCT was applied to evaluate tumor volume response (TVR), motion, and center coordinates during radiotherapy in 67 eligible individuals with lung cancer diagnoses. The differences between 4D CBCT and 3D CBCT in different registration methods were compared. TVR was observed during treatment in 41% of patients (28/67), with a mean volume reduction of 41.7% and a median time to TVR of 19 days. Tumor motion was obvious in 16 patients, with a mean value of 0.52 cm (0.22 to 1.34 cm), and in 3 of 6 tumors close to the diaphragm (0.28 to 0.66 cm). Gray value registration based on mean density projection could still achieve close results to the 4D gray value registration. However, when the registration was based on bone alone, partial off-targeting occurred in the treatment in 41.8% of cases. The off-target rate was 19.0% when the tumor motion was ≤ 0.5 cm and 52.2% when the motion was > 0.5 cm. Tumor volume and motion of intrapulmonary lesions in individuals diagnosed with lung cancer varied significantly in the third week of radiotherapy. 4D CBCT may be more advantageous for isolated lesions without reference to relative anatomical structures or those near the diaphragm. Grayscale registration based on mean density projection is feasible.

Identifiants

pubmed: 37069641
doi: 10.1186/s13014-023-02259-8
pii: 10.1186/s13014-023-02259-8
pmc: PMC10108471
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

69

Subventions

Organisme : Beijing Municipal Science and Technology Commission
ID : No.Z151100004015052
Organisme : Beijing Municipal Science and Technology Commission
ID : No.Z151100004015052
Organisme : Beijing Municipal Science and Technology Commission
ID : No.Z151100004015052
Organisme : Beijing Municipal Science and Technology Commission
ID : No.Z151100004015052
Organisme : Beijing Municipal Science and Technology Commission
ID : No.Z151100004015052
Organisme : Beijing Municipal Science and Technology Commission
ID : No.Z151100004015052

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s).

Références

J Natl Compr Canc Netw. 2021 Mar 02;19(3):254-266
pubmed: 33668021
Br J Radiol. 2015 Sep;88(1053):20140620
pubmed: 26183932
Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1618-24
pubmed: 18035215
Radiat Oncol. 2012 Jun 08;7:81
pubmed: 22682767
J Radiat Res. 2013 Sep;54(5):950-6
pubmed: 23564841
Radiol Phys Technol. 2012 Jul;5(2):138-47
pubmed: 22367851
Acta Oncol. 2010 Oct;49(7):1192-8
pubmed: 20831512
Chin Med J (Engl). 2022 Feb 9;135(5):584-590
pubmed: 35143424
Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):578-86
pubmed: 18374499
Acta Oncol. 2006;45(7):915-22
pubmed: 16982558
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):567-74
pubmed: 19046825
J Radiat Res. 2017 Nov 1;58(6):854-861
pubmed: 28992047
Radiother Oncol. 2009 Jun;91(3):288-95
pubmed: 18835650
Radiother Oncol. 2013 Mar;106(3):312-6
pubmed: 23395064

Auteurs

Muyasha Abulimiti (M)

National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China.

Xu Yang (X)

Department of Radiation Oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

Minghui Li (M)

Department of Radiation Oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

Fukui Huan (F)

Department of Radiation Oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

Yanxin Zhang (Y)

Department of Radiation Oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

Liang Jun (L)

Department of Radiation Oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. liang23400@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH